Parallax Volatility Advisers
ARIA

Parallax Volatility Advisers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Parallax Volatility Advisers’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-45,000
Closed -$560K – 5224
2016
Q4 		$560K Buy
+45,000
New +$542K ﹤0.01% 1454
2016
Q3 		– Sell
-70,000
Closed -$517K – 4469
2016
Q2 		$517K Buy
+70,000
New +$525K ﹤0.01% 1448

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Parallax Volatility Advisers's ARIA Position: Q4 2016 in Review

Parallax Volatility Advisers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 97,592 shares — an estimated $1.18M sold.

Parallax Volatility Advisers first reported a position in ARIA in Q1 2014 and held it in 6 quarters. The position peaked at $2.5M in Q2 2016. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • Parallax Volatility Advisers reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Parallax Volatility Advisers sold 97,592 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $1.18M.
  • Parallax Volatility Advisers first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 6 quarters.
  • Parallax Volatility Advisers's Ariad Pharmaceuticals Inc position peaked at $2.5M in Q2 2016.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on Parallax Volatility Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.